EXHIBIT 12. STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS FROM CONTINUING OPERATIONS TO FIXED CHARGES (Unaudited) Eli Lilly and Company and Subsidiaries (Dollars in millions) Nine Months Ended September 30, Years Ended December 31, ---------------------------------------------------- 1999 1998 1997 1996 1995 1994 ------------------------------------------------------------------- Consolidated Pretax Income from Continuing Operations before Extraordinary Item.................. $2,221.7 $2,665.0 $2,901.1 $2,131.3 $1,866.6 $1,693.3 Interest from Continuing Operations and Other Fixed Changes....................... 152.6 198.3 253.1 323.8 323.9 128.7 Less Interest Capitalized during the Period from Continuing Operations............... (19.8) (17.0) (20.4) (35.8) (38.3) (25.4) ------------------------------------------------------------------- Earnings.............................. $2,354.5 $2,846.3 $3,133.8 $2,419.3 $2,152.2 $1,796.6 =================================================================== Fixed Charges /1/..................... $ 152.7 $ 200.5 $ 256.8 $ 328.5 $ 323.9 $ 128.7 =================================================================== Ratio of Earnings to Fixed Charges....................... 15.4 14.2 12.2 7.4 6.6 14.0 =================================================================== /1/ Fixed charges include interest from continuing operations for all years presented and beginning in 1996, preferred stock dividends. 19